About Centro de Investigaciones Medicas Temperley
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Clinical Trials at Centro de Investigaciones Medicas Temperley
During the past decade, Centro de Investigaciones Medicas Temperley conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
A Study of Tirzepatide (LY3298176) on the Reduction on Morbidity and Mortality in Adults With Obesity
2022-10-11
2027-10-07
Recruiting
15,000
A Study to Learn How Well the Study Treatment Asundexian Works and How Safe it is Compared to Apixaban to Prevent Stroke or Systemic Embolism in People With Irregular and Often Rapid Heartbeat (Atrial Fibrillation), and at Risk for Stroke
2022-12-05
2025-08-25
Recruiting
18,000
Clinical Trials Sponsors and Collaborators
Clinical Trials Conditions at Centro de Investigaciones Medicas Temperley
According to Clinical.Site data, the most researched conditions in "Centro de Investigaciones Medicas Temperley" are
"Atrial Fibrillation" (1 trials), "Obesity" (1 trials), "Overweight" (1 trials) and "Prevention of Stroke or Systemic Embolism" (1 trials). Many other conditions were trialed in "Centro de Investigaciones Medicas Temperley" in a lesser frequency.
Clinical Trials Intervention Types at Centro de Investigaciones Medicas Temperley
Most popular intervention types in "Centro de Investigaciones Medicas Temperley" are "Drug" (2 trials). Other intervention types were less common.
The name of intervention was led by "Apixaban" (1 trials), "Apixaban matching placebo" (1 trials), "Asundexian (BAY2433334)" (1 trials), "Asundexian matching placebo" (1 trials) and "Placebo" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Centro de Investigaciones Medicas Temperley
The vast majority of trials in "Centro de Investigaciones Medicas Temperley" are
2 trials for "All" genders.
Clinical Trials Status at Centro de Investigaciones Medicas Temperley
Currently, there are NaN active trials in "Centro de Investigaciones Medicas Temperley".
undefined are not yet recruiting,
2 are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were undefined completed trials in Centro de Investigaciones Medicas Temperley,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Centro de Investigaciones Medicas Temperley, 0 "Phase 1"
clinical trials were conducted, 0 "Phase 2" clinical
trials and 2 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".